Penn Medicine Abramson Cancer Center


 

BCMA - Based Immunotherapy for Myeloma: Belantamab Mafodotin, CAR-T Cells & Bispecific Antibodies

288 views
February 24, 2020
Comments 0
Login to view comments. Click here to Login